We have recently identified a novel murine glycoprotein termed sgp-60, which is expressed on the cell surface of T and B lymphocytes. Because of the profound modulatory effects of sgp-60 on activation through the T cell receptor/CD3 complex, we have examined the membrane attachment domain of the molecule. sgp-60 is not expressed on the surface of variants of a T-T hybridoma cell line that are defective in glycosylphosphatidylinositol (GPI) anchor biosynthesis. In wild-type but not in mutant cells, sgp-60 can be labeled with palmitic acid. Furthermore, the molecule can be removed from the cell surface of both T and B lymphocytes by enzymatic digestion with a phosphatidylinositol-specific phospholipase C. We conclude that the sgp-60 molecule is linked to the plasma membrane via a GPI anchor.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/eji.1830210818 | DOI Listing |
Cell Immunol
July 1994
Cell Enzymology Unit, Kennedy Institute of Rheumatology, Bute Gardens, London, United Kingdom.
In this study we have investigated the expression and function of the murine CD2 receptor in T cells. The surface level of CD2 increased between 300 and 400% when T cells were activated, which also induced a rapid increase of nearly 40-fold in the steady-state levels of CD2 mRNA. Although the activated lymphocytes were found to internalize and degrade nearly 50% of membrane-bound CD2, in addition to shedding the CD2 receptor from the cell surface, this does not account for the discrepancy between the increase in mRNA and antigen levels during activation.
View Article and Find Full Text PDFEur J Immunol
June 1993
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
We recently showed that CD48 is the major counter-receptor for CD2 in the murine system. To examine whether sgp-60, which has been proposed as the murine homologue of human LFA-3, is another ligand for mouse CD2, we performed the characterization of sgp-60 by using mouse CD2-human IgG chimeric protein (mCD2Rg) and anti-mouse monoclonal antibodies (mAb). Anti-sgp-60 mAb 5-8A10, as well as anti-mouse CD48 mAb HM48-1 completely inhibited the binding of mCD2Rg at the ligand site.
View Article and Find Full Text PDFEur J Immunol
August 1991
Department of Pathology, Harvard Medical School, Boston, MA.
We have recently identified a novel murine glycoprotein termed sgp-60, which is expressed on the cell surface of T and B lymphocytes. Because of the profound modulatory effects of sgp-60 on activation through the T cell receptor/CD3 complex, we have examined the membrane attachment domain of the molecule. sgp-60 is not expressed on the surface of variants of a T-T hybridoma cell line that are defective in glycosylphosphatidylinositol (GPI) anchor biosynthesis.
View Article and Find Full Text PDFJ Immunol
October 1990
Department of Pathology, Harvard Medical School, Boston, MA 02115.
T cell activation depends not only on the expression of a TCR, but also on that of accessory molecules that function in cell-cell adhesion and/or signal transduction. The subject of this report is the biochemical and functional characterization of what appears to be a novel murine lymphocyte cell surface antigen, provisionally termed sgp-60. Extensive, higher-order cross-linking of this glycoprotein with an anti-sgp-60 mAb and a second-step antibody reagent results in the activation of resting CD4+ T cells in the presence of a second signal.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!